Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 09:29 am Sale | 13G | SYNTHORX INC THOR | Camber Capital Management LP | 1,000,000 3.09% | -862,116 (-46.30%) | View |
| 2020-02-14 09:28 am Sale | 13G | ZYMEWORKS INC ZYME | Camber Capital Management LP | 0 0% | -2,166,000 (Position Closed) | View |
| 2020-02-14 09:25 am Sale | 13G | CLOVIS ONCOLOGY INC CLVS | Camber Capital Management LP | 0 0% | -2,800,000 (Position Closed) | View |
| 2019-10-15 09:51 am Unchanged | 13G | AMAG PHARMACEUTICALS INC AMAG | Camber Capital Management LP | 4,390,000 12.9% | 0 (Unchanged) | View |
| 2019-09-20 08:03 am Purchase | 13D | AMAG PHARMACEUTICALS INC AMAG | Camber Capital Management LP | 4,390,000 12.9% | 1,740,000 (+65.66%) | View |
| 2019-08-15 12:26 pm Purchase | 13G | GLYCOMIMETICS INC GLYC | Camber Capital Management LP | 3,500,000 8.1% | 3,500,000 (New Position) | View |
| 2019-07-29 2:27 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Camber Capital Management LP | 2,950,000 5.55% | 1,050,000 (+55.26%) | View |
| 2019-06-17 11:26 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Camber Capital Management LP | 1,561,915 5.7% | 1,561,915 (New Position) | View |